Reuters logo
BRIEF-Circassia Pharmaceuticals Says ‍Tudorza Meets Primary Endpoints In Ascent Study​
December 4, 2017 / 7:38 AM / 12 days ago

BRIEF-Circassia Pharmaceuticals Says ‍Tudorza Meets Primary Endpoints In Ascent Study​

Dec 4 (Reuters) - CIRCASSIA PHARMACEUTICALS PLC:

* TUDORZA® MEETS PRIMARY ENDPOINTS IN ASCENT STUDY​

* TUDORZA® SUCCESSFULLY MET BOTH PRIMARY ENDPOINTS IN ASCENT PHASE IV STUDY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below